Analysts at GMI Research, Needle Free Injection Systems Market is Predicted to Expand at a Significant CAGR of 16.2% during 2022-2029.

Key Drivers

Factors driving growth of Needle Free Injection Systems includes increasing demand for self-injection devices, growing prevalence of cancer, diabetes, and infectious diseases around the world, rising focus of pharmaceutical manufacturers on developing innovative delivery solution for biosimilars and improvements in the living standards. According to the report published by World Health Organization (WHO), the number of people suffering from diabetes have increased from 108 million in 1980 to 422 million in 2014, prevalence of diabetes is increasingly seen in low- and middle-income countries, which will boost the demand for needle free injection systems in the approaching years. In addition, the increasing investments by major companies on research and development, strategic mergers, and collaborations between leading players, rise in the launch of new products, favorable Government policies, and growing disposable incomes, are further contributing towards the market growth.

Moreover, growing adoption of advanced technologies such as Artificial Intelligence (AI) and Bar Code Identification and telecare by pharmacists and clinicians to store patients planned proceedings and records and smoothen the vaccination progress, which is expected to accelerate the market growth in the coming years. Needle free injection systems eliminates the risks of infection, ensures faster drug delivery, enables self-administration of drugs, provides medication more uniformly in the dermis and can be used multiple times, are some of the features pushing the market growth. Increase in consumers spending on healthcare products, growing geriatric population, and rising incidence of communicable diseases due to needlestick injuries, are further pushing the demand for needle free injection systems. However, high cost of developing needle free injection systems and growth in the alternative route of drug administration, are hampering market’s growth.

To have an edge over the competition by knowing the market dynamics and current trends of “Needle Free Injection Systems Market”, request for Sample Report here

Product: Segment Analysis

Based on Product, Fillable Needle Free Injectors segment is predicted to capture the highest market share during the forecast period. Increasing use of fillable needle free injections in vaccination, insulation, and other drug delivery

Technology: Segment Analysis

Based on Technology, Jet Based Needle Free Injectors segment is projected to dominate the market over the forecast period. As per the Needle Free Injection Systems Market Forecast, jet-based needle free injectors provide rapid drug administration, enhances dosage accuracy, and diffuses better in the tissue at a faster response rate, which are pushing the segment’s growth. In addition, needle free jet injection enhances safety by eliminating needles from the process of administering vaccines, eliminates the need to transport huge volumes of sharps, can deliver vaccines intradermally minimizes the risk of needle sticks, are some of the features further propelling the segment’s growth.

Do you want to know more about the Research process and detailed Methodology, Request Research Methodology of this report

Regional Analysis

Based on Region, Europe emerged as the fastest growing region. Presence of the leading players such as Medical International Technology, Inc. (MIT), Injex Pharma AG and European Pharma Group, increase in the number of regulatory approvals for new injection systems, rise in consumers spending on healthcare, favorable government policies and growing prevalence of chronic diseases such as cancer and diabetes and cancer across, are some of the factors pushing the market growth in Europe.

On contrary, Asia-Pacific region is anticipated to expand at the highest market share during the forecast period. Increasing prevalence of infectious disease across India, China, and Indonesia, rising geriatric population, technological advancements in needle free injection systems, rapid urbanization and growing per capita incomes, are some of the important factors augmenting the market growth in Asia-Pacific region.

In case, any of your pain points areas are not covered in the current scope of this report, Request for Free Customization here

Top Market Players

The report also profiles the major companies active in this field, including Antares Pharma, Inc., Endo International PLC., Pharmajet, Bioject Medical Technologies Inc. (Acquired By Inovio Pharmaceuticals, Inc.) , Medical International Technology, Inc. (MIT) , Injex Pharma AG , National Medical Products, Inc. , Valeritas, Inc. , European Pharma Group, Penject Corporation , Crossject.

Key Developments

• • In August 2012, INJEX Pharma AG and American Healthcare Products Inc., signed an agreement to market needle-free syringe INJEX 30 across West Coast States of USA.
  • In April 2022 Halozyme Therapeutics, Inc., acquired Antares for $5.60 per share in cash. The transaction was valued around USD 960 million and was unanimously approved by both the Halozyme and Antares Boards of Directors.
  • In October 2013 Bioject Medical Technologies Inc., signed a distribution agreement with Fondaco PTE, LTD, a premier medical supplies company based in Singapore. Under the terms of this agreement, Fondaco will exclusive distribute Bioject’s commercial needle-free injection products across Singapore, Indonesia, and Malaysia.
  • In February 2020 Valeritas Holdings, Inc., publicizes the agreement to sell substantially all the business to Zealand Pharma A/S (“Zealand”), a Denmark-based biotechnology company. Valeritas will continue operating its business as usual and acquired a commitment for debtor-in-possession (“DIP”) financing from HB Fund LLC.

For detailed scope of the “Needle Free Injection Systems Market” report request a Sample Copy of the report

Report Coverage	Details
Market Revenues (2020)	USD Million
Market Base Year	2021
Market Forecast Period	2022-2029
Base Year & Forecast Units	Revenues (USD Million)
Market Segment	By Product, By Technology, By Region
Regional Coverage	Asia Pacific, Europe, North America, and RoW
Companies Profiled	Antares Pharma, Inc., Endo International PLC., Pharmajet, Bioject Medical Technologies Inc. (Acquired By Inovio Pharmaceuticals, Inc.) , Medical International Technology, Inc. (MIT) , Injex Pharma AG , National Medical Products, Inc. , Valeritas, Inc. , European Pharma Group, Penject Corporation , Crossject, among others; a total of 10 companies covered.
25% Free Customization Available	We will customize this report up to 25% as a free customization to address our client’s specific requirements

Global Needle Free Injection System Market by Product

• • Fillable Needle Free Injectors
  • Prefilled Needle Free Injectors

Global Needle Free Injection System Market by Technology

• • Jet Based Needle Free Injectors
  • Spring Based Needle Free Injectors
  • Laser Powered Needle Free Injectors
  • Vibration Based Needle Free Injectors

Global Needle Free Injection System Market by Region

• • North America Global Needle Free Injection Systems Market (Option 1: As a part of the free 25% customization)
    • By Product
    • By Technology
    • US Market All-Up
    • Canada Market All-Up
  • Europe Global Needle Free Injection Systems Market (Option 2: As a part of the free 25% customization)
    • By Product
    • By Technology
    • UK Market All-Up
    • Germany Market All-Up
    • France Market All-Up
    • Spain Market All-Up
    • Rest of Europe Market All-Up
  • Asia-Pacific Global Needle Free Injection Systems Market (Option 3: As a part of the free 25% customization)
    • By Product
    • By Technology
    • China Market All-Up
    • India Market All-Up
    • Japan Market All-Up
    • Rest of APAC Market All-Up
  • RoW Global Needle Free Injection Systems Market (Option 4: As a part of the free 25% customization)
    • By Product
    • By Technology
    • Brazil Market All-Up
    • South Africa Market All-Up
    • Saudi Arabia Market All-Up
    • UAE Market All-Up
    • Rest of world (remaining countries of the LAMEA region) Market All-Up

Global Needle Free Injection System Market Competitive Landscape

• • Major Players and their Market Share Analysis
  • New product launches
  • Mergers and acquisitions
  • Collaborations, partnerships, agreements and joint ventures